IP Library › Granted Patent US 7,985,766
Granted Patent B2
US 7,985,766 · App. 11/882,109 · Granted Jul 26, 2011

Combination of anticholineric and β mimetics for the treatment of respiratory diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,985,766
App. No.
11/882,109
Granted
Jul 26, 2011
Kind
B2
Abstract

The present invention describes a combination of an anticholinergic, such as R,R-glycopyrrolate, and a β mimetic, such as tormoterol, for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma.

Claims (7)

1. A method for the treatment of chronic obstructive pulmonary disease (COPD) or asthma in a patient suffering from COPD or asthma comprising administration of a combination of R,R-glycopyrrolate and formoterol or physiologically acceptable salt(s) thereof.

2. The method of claim 1 wherein the daily dose of R,R-glycopyrrolate is between 5 and 500 μg.

3. The method of claim 1 wherein the daily dose of formoterol is between 200 and 5,000 μg.

4. The method of claim 1 wherein the combination is administered in an inhalable aerosol.

5. The method of claim 1 wherein the combination is administered in an inhalable dry powder.

6. The method of claim 1 wherein the R,R-glycopyrrolate and formoterol are presented in fixed or free combination for simultaneous, sequential or separate administration, optionally together with a suitable excipient, adjunct or additive in a pharmaceutical form suitable for inhalative application.

7. The method of claim 1 wherein the patient is a human or horse.